Rx drug information, pharmaceutical research, clinical trials, news, and more
S9511: a Southwest Oncology Group phase II study of trimetrexate, 5-fluorouracil, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach. [2010.04]
Trimetrexate and folinic acid: a valuable salvage option for Pneumocystis jirovecii pneumonia. [2009.06.19]
The protection against trimetrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-fluorouracil/trimetrexate. [2006.11]
A phase I/II study of trimetrexate and capecitabine in patients with advanced refractory colorectal cancer. [2005.10]
Complete regression of large solid tumors using engineered drug-resistant hematopoietic cells and anti-CD137 immunotherapy. [2006.08]
Dihydrofolate reductase as a target for chemotherapy in parasites. [2007]
Raloxifene and selective cell cycle specific agents: a case for the inclusion of raloxifene in current breast cancer treatment therapies. [2007.05]
Commentary: a case for minimizing folate supplementation in clinical regimens with pemetrexed based on the marked sensitivity of the drug to folate availability. [2007.07]
Anticancer agents against malaria: time to revisit? [2010.03]
Clinical efficacy of first- and second-line treatments for HIV-associated Pneumocystis jirovecii pneumonia: a tri-centre cohort study. [2009.12]
Gateways to clinical trials. [2010.12]
All Rights reserved - Copyright DrugLib.com, 2006-2017